Publications in collaboration with researchers from Instituto de Investigación Biomédica de Salamanca (4)

2024

  1. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

    Neuro-Oncology, Vol. 26, Núm. 7, pp. 1230-1246

2021

  1. Recent advances on immunosuppressive drugs and remyelination enhancers for the treatment of multiple sclerosis

    Current Pharmaceutical Design, Vol. 27, Núm. 30, pp. 3273-3280

2019

  1. Fatty acids and antioxidants in multiple sclerosis: Therapeutic role of GEMSP

    Current Pharmaceutical Design, Vol. 25, Núm. 4, pp. 376-380

2017

  1. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK

    Stem Cell Reports, Vol. 9, Núm. 2, pp. 451-463